head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2020, vol. 26, issue4
Subject Area: Medicine
DOI: 10.5272/jimab.2020264.3443
Published online: 19 November 2020

Case report

J of IMAB. 2020 Oct-Dec;26(4):3443-3448
Tatyana Telbizova1ORCID logo Corresponding Autoremail, Ivan Aleksandrov2ORCID logo, Mariana Arnaoudova1ORCID logo,
1) Department of psychiatry and medical psychology, Medical University - Varna, Bulgaria,
2) Department of Health Care, Sliven Affiliate, Medical University - Varna, Bulgaria.

Cushing’s syndrome may present with various psychiatric disorders which can lead to a misdiagnosis at the beginning, deterioration of the course of the disease and life-threatening complications. The most common psychiatric disorder is atypical depression. During the initial stages of the disease, the somatic symptoms of Cushing’s syndrome can be subtle, difficult to identify, especially when the psychiatric symptoms are dominant.
Objective: The aim of the present article is to report a case of a 24-year-old woman with a Cushing’s syndrome, caused by the adrenal adenoma. The onset of the disease is a suicidal attempt. Family history is significant for psychiatry disorder. The belated diagnosis led to somatic and psychiatry complications of the disease – sepsis and persisting high suicidal risk. The dynamic change in the patient’s mental state – from a severe depressive episode with atypical symptoms to psychosis with single catatonic symptoms – correlated well with the gradual increase of the plasma cortisol levels. The antidepressant and subsequent antipsychotic medication turned out to be ineffective. The surgical treatment, followed by a normalization of the cortisol levels was a key to the successful outcome and the reduction of self-aggression risk.
Conclusion: The early diagnosis and timely treatment of Cushing’s syndrome decrease the risk of multiple complications. The shift from atypical depression to psychosis with catatonic symptoms correlates with the worsening of the hormonal imbalance. The signs of atypical depression in Cushing's syndrome, resistant to the antidepressant medication, could be considered as relatively specific symptoms, guiding specialists to its somatogenic origin for the proper diagnosis.

Keywords: Cushing’s syndrome, hypercortisolemia, atypical depression, somatogenic psychosis, catatonic symptoms,

pdf - Download FULL TEXT /PDF 503 KB/
Please cite this article as: Telbizova T, Aleksandrov I, Arnaoudova M. Dynamics of psychiatric symptoms in Cushing’s syndrome. J of IMAB. 2020 Oct-Dec;26(4):3443-3448. DOI: 10.5272/jimab.2020264.3443

Corresponding AutorCorrespondence to: Tatyana Telbizova, MD, Department of psychiatry and medical psychology, MHAT St. Marina, Medical University-Varna; 1, Hristo Smirnenski Str., 9010 Varna, Bulgaria; E-mail: ttelbizova@gmail.com

1. Sievers C, Stalla GK. Psychiatric Disease in Hypothalamic-Pituitary Disorders. In: The Pituitary. 4th Edition. Academic press. 2017. Section II. Chapter 14. pp.413-419. [Crossref]
2. Arnaudova-Zhekova MD. Pathophysiological, clinical diagnostic and therapeutic aspects of delirium. University Publishing House of Medical University – Varna. 2017; 26-44.
3. Steinberg H, Kirkby KC, Himmerich. The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy. Int J Mol Sci. 2015 Dec 4;16(12):28841-69. [PubMed]
4. Laane CL. Cushing’s syndrome associated with obliterative arterial disease and multiple subcutaneous nodules. (Ehlers-Danlos syndrome?) Acta Med Scand. 1954;148(4):323-5. [PubMed]
5. Newell-Price JDC. Cushing Disease. In: The Pituitary. 4th Edition. Academic Press. 2017. Section III. Chapter 17. pp.515-571. [Crossref]
6. Hirsch D, Shimon I, Manisterski Y, Aviran-Barak N, Amitai O, Nadler V, et al. Cushing’s syndrome: comparison between Cushing’s disease and adrenal Cushing’s. Endocrine. 2018 Dec;62(3):712-720. [PubMed]
7. Nieman LK. Recent Updates on the Diagnosis and Management of Cushing’s Syndrome. Endocrinol Metab (Seoul).2018 Jun;33(2):139-146. [PubMed]
8. Alwani RA, Schmit Jongbloed LW, de Jong FH, van der Lely AJ, de Herder WW, Feelders RA. Differentiating between Cushing’s disease and pseudo-Cushing’s syndrome: comparison of four tests. Eur J Endocrinol. 2014 Mar 8;170(4):477-86. [PubMed]
9. Findling J, Raff H. Diagnosis of endocrine disease: Differentiation of pathologic/neoplastic hypercortisolism (Cushing’s syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing’s syndrome). Eur J Endocrinol. 2017 May;176(5):R205-R216. [PubMed]
10. Starkman MN, Schteingart DE, Schork MA. Depressed mood and other psychiatric manifestations of Cushing’syndrome: relationship to hormone levels. Psychosom Med. 1981 Feb;43(1):3-18. [PubMed]
11. Dorn LD, Burgess ES, Dubbert B, Simpson SE, Friedman TC, Kling M, et al. Psychopathology in patients with endogenous Cushing’s syndrome: ‘atypical’ or melancholic features. Clin Endocrinol (Oxf). 1995 Oct;43:433-42. [PubMed]
12. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP. The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab. 1997; 82(3):912-9. [PubMed]
13. Haskett RF. Diagnostic categorization of psychiatric disturbance in Cushing’s Syndrome. Am J Psychiatry. 1985 Aug;142(8):911-6. [PubMed]
14. Raff H. Cushing Syndrome: Update on Testing. Endocrinol Metab Clin North Am. 2015 Mar;44(1):43-50. [PubMed]
15. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2003 Dec;88(12):5593-602. [PubMed]
16. Pivonello R, Simeoli C, De Martino MC, Cozzolino A, De Leo M, Iacuaniello D,  et al. Neuropsychiatric disorders in Cushing’s syndrome. Front Neurosci. 2015 Apr 20;9:129. [PubMed]
17. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F. Clinical correlates of major depression in Cushing’s disease. Psychopathology. 1998 Nov-Dec;31(6):302-6. [PubMed]
18. Loosen PT, Chambliss B, DeBold CR, Shelton R, Orth DN. Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry. 1992 Jul;25(4):192-198. [PubMed]
19. Lojko D, Rybakowski JK. Atypical depression: current perspectives. Neuropsychiatr Dis Treat. 2017 Sep 20;13:2447-2456. [PubMed]
20. Ivanov VB. [Differential diagnosis of psychiatric disorders.] [in Bulgarian] Sofiia: Meditsina i fizkultura. 1991. pp.108-198.
21. Tsai W-T, Tsai S-J, Yang AC. Cyclic Cushing’s syndrome mimicking bipolar disorder. Psychiatry and Clinical Neurosciences. 2016 Jan;70(1):71. [PubMed]
22. Claser GH. Psychotic reactions induced by corticotropin (ACTH) and cortisone. Psychosom Med. 1953 Jul-Aug; 15(4):280-91. [PubMed]
23. Kelly WF. Psychiatric aspects of Cushing’s syndrome. QJM. 1996 Jul;89(7):543-51. [PubMed]
24. Hirsch D, Orr G, Kantarovich V, Hermesh H, Stern E, Blum I. Cushing’s syndrome presenting as a schizophrenia-like psychotic state. Isr J Psychiatry Relat Sci. 2000; 37(1):46-50. [PubMed]
25. Dong TS, Henry JT, Stanley K, Pannain S. Catatonia Induced by an ACTH-Secreting Neuroendocrine Tumor: A Case Report. AACE Clinical Case Reports. 2015 Autumn;1(4):e245-e249. [Crossref]
26. Brzana J, Yedinak CG, Hameed N, Plesiu A, McCartney S, Fleseriu M. Polycystic ovarian syndrome and Cushing’s syndrome: a persistent diagnostic quandary. Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:145-8. [PubMed]
27. Zaimov K. [Psychopathology. Lecture course for psychology students.] [in Bulgarian] Science and art, Sofia. 1971; 103-126.
28. Pereira AM, Tiemensma J, Romijn JA. Neuropsychiatric Disorders in Cushing’s Syndrome. Neuroendocrinology. 2010; 92(suppl 1):65-70. [PubMed]
29. Bilgin YM, van der Wiel HE, Fischer HR, De Herder WW. Treatment of severe psychosis due to ectopic Cushing’s syndrome. J Endocrinol Invest. 2007  Oct;30(9):776-9. [PubMed]
30. Knadler MP, Lobo E, Chappell J, Bergstrom R. Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011 May;50(5):281-94. [PubMed]
31. Zhang X, Xiang Q, Zhao X, Ma L, Cui Y. Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: A systematic review and meta-analysis. J Clin Pharm Ther. 2019 Apr;44(2):163-173. [PubMed]
32. Karanikas Е, Garyfallos G. Role of cortisol in patients at risk for psychosis mental state and psychopathological correlates: A systematic review. Psychiatry Clin Neurosci. 2015 May;69(5):268-82. [PubMed].

Received: 17 November 2019
Published online: 19 November 2020

back to Online Journal